Search
Search
Close this search box.

A sneak peek at the Republican-led States Reform Act

The States Reform Act hasn’t been introduced yet, but thanks to Insider, we can take a closer look at what’s being proposed in South Carolina Rep. Nancy Mace’s cannabis legalization bill. 



Treated like alcohol

The bill would regulate cannabis much like alcohol. Cannabis would no longer be included in the Controlled Substances Act, and the minimum age to buy would be 21. The regulator for adult-use would also be the same — the Tax and Trade Bureau (although the Food and Drug Administration would regulate medical cannabis). And similar to hemp or hops, the US Department of Agriculture would regulate cultivation.

Tax talk

The excise tax would be set at three per cent under the proposed Cannabis Revenue Act. That would bring an anticipated $4 billion over 10 years, and it wouldn’t increase within that time. A portion of those funds (to be decided by Congress) would be earmarked for something called the Law Enforcement Retraining and Successful Second Chances Fund, which would assist people who have been incarcerated, veterans, people with opioid addiction, small business and community police forces.

Equity and cross-border trade

The bill would allow for a permit for interstate commerce, with details to be formed by the secretary of the Treasury, such as seed-to-sale tracking. Like any other business, cannabis companies could apply for loans.

And perhaps surprisingly, the States Reform Act would also expunge the criminal records for nonviolent cannabis crimes with a few exceptions, such as DUIs or involvement with international drug cartels. Pending charges and convictions for nonviolent cannabis crimes would be dropped, and those incarcerated would be released within 14 days.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?